Cargando…

Covid-19, vaccine decision and schizophrenia

Detalles Bibliográficos
Autores principales:	Samaâli, S., Karoui, M., Maaroufi, A., Kamoun, R., Nefzi, H., Ben Salah, K., Ellouze, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	L'Encéphale, Paris. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818340/ https://www.ncbi.nlm.nih.gov/pubmed/35221023 http://dx.doi.org/10.1016/j.encep.2022.01.004

Ejemplares similares

Negative symptoms and associated factors in older people with schizophrenia
por: Karoui, M., et al.
Publicado: (2023)

Translation and validation of the Arabic version of the “Suicide Behavioral Attitude Questionnaire”
por: Karoui, Mehdi, et al.
Publicado: (2022)

Problematic mobile phone use among medical students and professionals: Its impact on sleep quality and depressive symptoms
por: Abdellatif, M., et al.
Publicado: (2023)

Sleep quality in first-episode schizophrenia patients
por: Abdellatif, M., et al.
Publicado: (2023)

Profile of substance use disorders in elderly psychiatric inpatients
por: Karoui, M., et al.
Publicado: (2023)

Residents’ Perspectives on Geriatric Psychiatry: A Tunisian Survey.
por: Karoui, M., et al.
Publicado: (2023)

An auditory Charles Bonnet Syndrome managed with psychological intervention: A case report
por: Karoui, M., et al.
Publicado: (2023)

Sleep disorders in patients with a first psychotic episode: a case-control study
por: Abdellatif, M., et al.
Publicado: (2023)

Comorbid somatic conditions among older patients with major mental illness: A retrospective inpatients study.
por: Karoui, M., et al.
Publicado: (2023)

Unmasking of schizophrenia following COVID vaccination
por: Laxmi, Raj, et al.
Publicado: (2023)

COVID 19 vaccination of persons with schizophrenia in India – Need for imperative action!
por: Suhas, Satish
Publicado: (2021)

Severe breakthrough COVID‐19 infections in vaccinated patients with schizophrenia in Israel
por: Tzur Bitan1,2, Dana, et al.
Publicado: (2022)

Patients with schizophrenia are under‐vaccinated for COVID‐19: a report from Israel
por: Bitan, Dana Tzur
Publicado: (2021)

Autoimmune diseases and vaccines against COVID-19. Decision-making in uncertain scenarios()
por: Calvo Elías, Alberto E., et al.
Publicado: (2022)

Is schizophrenia research relevant during the COVID-19 pandemic?
por: Cowan, Henry R.
Publicado: (2020)

Coping strategies among medical and paramedic frontline healthcare workers during the coronavirus pandemic
por: Kammoun, I., et al.
Publicado: (2022)

Factors Affecting COVID-supplementalsupplementalsupplementalsupplemental19 Vaccination Decision: Findings from an Online Survey from India
por: Nair, Pradeep M. K., et al.
Publicado: (2023)

A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts
por: Schor, Shayna H., et al.
Publicado: (2022)

Mental disorders during pregnancy and postpartum period
por: Kammoun, I., et al.
Publicado: (2021)

Recurrent floating common carotid artery thrombus related to COVID-19: A case report
por: Bouchal, S., et al.
Publicado: (2023)

Commentary to “Schizophrenia and COVID-19 Delirium”, an update
por: Palomar-Ciria, Nora, et al.
Publicado: (2020)

Case report: Schizophrenia and hypertrophic osteoarthropathy, a rare syndrome hiding a life‐threatening condition
por: Baklouti, Emna, et al.
Publicado: (2022)

Schizophrenia Secondary to COVID-19 and Tuberculosis: A Case Series of Post-Infection Schizophrenia
por: Chakraborty, Avik, et al.
Publicado: (2022)

First episode psychosis Post-COVID 19 infection : case report
por: Dhakouani, S., et al.
Publicado: (2023)

Pfizer: The miracle vaccine for COVID-19?
por: Badiani, A.A., et al.
Publicado: (2020)

Comment on “Increased in-hospital mortality from COVID-19 in patients with schizophrenia”. Considering the prevalence and protective factors of COVID-19 in patients with schizophrenia
por: Ekinci, O., et al.
Publicado: (2022)

Decisive or impulsive? Re-examining Africa’s lockdown response to COVID-19
por: Alaran, Aishat Jumoke, et al.
Publicado: (2022)

Resident Perspectives on COVID-19 in Psychiatric Decision-Making
por: Gallop, Amy, et al.
Publicado: (2020)

Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic
por: Nichols, Jessica, et al.
Publicado: (2020)

Schizophrenia and COVID-19: A bibliometric analysis of trends and themes
por: Shekhar, Suraj Kushe
Publicado: (2023)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Incidence and outcome of COVID-19 in patients with schizophrenia: A Study from India
por: Grover, Sandeep, et al.
Publicado: (2021)

SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA
por: Rendon-Quintero, Eduardo, et al.
Publicado: (2021)

Isolated abducens nerve palsy following Covid-19 vaccine
por: Khalili, M.R., et al.
Publicado: (2022)

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
por: Attias, Philippe, et al.
Publicado: (2021)

Bipolar disorders diagnosed in the elderly: Clinical and therapeutic particularities.
por: Karoui, M., et al.
Publicado: (2023)

De novo IgA vasculitis following adenovirus-based SARS-CoV-2 vaccination
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Acute macular neuroretinopathy after COVID-19 vaccine
por: Michel, T., et al.
Publicado: (2022)

Vaccination for COVID-19: benchmarks in public health and virus transmission
por: Lesser, K., et al.
Publicado: (2021)

COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa?
por: Ekwebelem, O.C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_klnn3pgp3crqgt0nbk5e3jv5o1